{"id":"https://openalex.org/W4362478591","doi":"https://doi.org/10.1158/1535-7163.22497700","title":"Supplementary Figure 1 from Targeting IGF-IR with Ganitumab Inhibits Tumorigenesis and Increases Durability of Response to Androgen-Deprivation Therapy in VCaP Prostate Cancer Xenografts","display_name":"Supplementary Figure 1 from Targeting IGF-IR with Ganitumab Inhibits Tumorigenesis and Increases Durability of Response to Androgen-Deprivation Therapy in VCaP Prostate Cancer Xenografts","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362478591","doi":"https://doi.org/10.1158/1535-7163.22497700"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22497700","doi":"https://doi.org/10.1158/1535-7163.22497700","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22497700","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Targeting_IGF-IR_with_Ganitumab_Inhibits_Tumorigenesis_and_Increases_Durability_of_Response_to_Androgen-Deprivation_Therapy_in_VCaP_Prostate_Cancer_Xenografts/22497700/1/files/39956047.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Targeting_IGF-IR_with_Ganitumab_Inhibits_Tumorigenesis_and_Increases_Durability_of_Response_to_Androgen-Deprivation_Therapy_in_VCaP_Prostate_Cancer_Xenografts/22497700/1/files/39956047.pdf","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002228936","display_name":"Cale D. Fahrenholtz","orcid":"https://orcid.org/0000-0002-5998-4003","observed_orcids":["https://orcid.org/0000-0002-5998-4003"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cale D. Fahrenholtz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019770407","display_name":"Pedro J. Beltran","orcid":"https://orcid.org/0000-0002-4103-6494","observed_orcids":["https://orcid.org/0000-0002-4103-6494"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pedro J. Beltran","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5088558562","display_name":"Kerry L. Burnstein","orcid":"https://orcid.org/0000-0002-7351-0963","observed_orcids":["https://orcid.org/0000-0002-7351-0963"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kerry L. Burnstein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.7734000086784363,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.7734000086784363,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.2199999988079071,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/igf-1-receptor","display_name":"IGF-1 receptor","score":0.8870000243186951},{"id":"https://openalex.org/keywords/ganitumab","display_name":"ganitumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.8399999737739563},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.8709999918937683},{"id":"https://openalex.org/keywords/vcap-xenograft","display_name":"VCaP xenograft","score":0.9629999995231628},{"id":"https://openalex.org/keywords/carcinogenesis","display_name":"carcinogenesis","score":0.9269999861717224},{"id":"https://openalex.org/keywords/treatment-response-durability","display_name":"treatment response durability","score":0.38499999046325684}],"concepts":[{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.8133901357650757},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.6088811755180359},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6003965735435486},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.4703787863254547},{"id":"https://openalex.org/C2777911890","wikidata":"https://www.wikidata.org/wiki/Q62614","display_name":"Androgen","level":3,"score":0.44292569160461426},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42072486877441406},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40010690689086914},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3987880051136017},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3264234662055969},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2821206748485565},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.11709153652191162}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.22497700","doi":"https://doi.org/10.1158/1535-7163.22497700","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22497700","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Targeting_IGF-IR_with_Ganitumab_Inhibits_Tumorigenesis_and_Increases_Durability_of_Response_to_Androgen-Deprivation_Therapy_in_VCaP_Prostate_Cancer_Xenografts/22497700/1/files/39956047.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22497700","doi":"https://doi.org/10.1158/1535-7163.22497700","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22497700","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Targeting_IGF-IR_with_Ganitumab_Inhibits_Tumorigenesis_and_Increases_Durability_of_Response_to_Androgen-Deprivation_Therapy_in_VCaP_Prostate_Cancer_Xenografts/22497700/1/files/39956047.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362478591.pdf","grobid_xml":"https://content.openalex.org/works/W4362478591.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362478422","https://openalex.org/W2109250201","https://openalex.org/W2009858998","https://openalex.org/W1933713383","https://openalex.org/W2037868046","https://openalex.org/W2159753688","https://openalex.org/W4321376120","https://openalex.org/W2211523930","https://openalex.org/W2033032904","https://openalex.org/W3028896781"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"65K,":[3],"Schematic":[4],"of":[5],"IGF-1R":[6],"Signaling":[7],"Pathways":[8]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2023-04-05T00:00:00"}